Silence Therapeutics plc Description Of Expected Volatility Share Options Granted
Silence Therapeutics plc (SLNCF) reported Description Of Expected Volatility Share Options Granted of 56.00% for the 12-month period ending 2022-12-31, per its 20-F filed 2023-03-15.
Discontinued › Notes
ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted · last filed 2023-03-15
| Period end | Description Of Expected Volatility Share Options Granted 12 month | Description Of Expected Volatility Share Options Granted 12 month as first filed |
|---|---|---|
| 2022-12-31 | 56.00% 20-F · filed 2023-03-15 | |
| 2021-12-31 | 74.00% 20-F · filed 2023-03-15 | 65.00% 20-F · filed 2022-03-17 |
| 2020-12-31 | 74.00% 20-F · filed 2023-03-15 | 70.00% 20-F · filed 2022-03-17 |
| 2019-12-31 | 70.00% 20-F · filed 2022-03-17 |